PortfoliosLab logo

ProShares Ultra Nasdaq Biotechnology

BIB
ETF · Currency in USD
ISIN
US74347R2141
CUSIP
74347R214
Issuer
ProShares
Inception Date
Apr 7, 2010
Region
North America (U.S.)
Category
Leveraged Equities
Leveraged
2x
Expense Ratio
0.95%
Index Tracked
NASDAQ Biotechnology Index (200%)
ETF Home Page
www.proshares.com
Asset Class
Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

BIBPrice Chart


Chart placeholderClick Calculate to get results
S&P 500

BIBPerformance

The chart shows the growth of $10,000 invested in ProShares Ultra Nasdaq Biotechnology on Apr 12, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $142,478 for a total return of roughly 1,324.78%. All prices are adjusted for splits and dividends.


BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (S&P 500)

BIBReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M3.51%
6M22.76%
YTD23.73%
1Y50.66%
5Y16.72%
10Y30.06%

BIBMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BIBSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ProShares Ultra Nasdaq Biotechnology Sharpe ratio is 1.16. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (S&P 500)

BIBDividends

ProShares Ultra Nasdaq Biotechnology granted a 0.00% dividend yield in the last twelve months, as of Sep 18, 2021. The annual payout for that period amounted to $0.00 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.01

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.15%

BIBDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (S&P 500)

BIBWorst Drawdowns

The table below shows the maximum drawdowns of the ProShares Ultra Nasdaq Biotechnology. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ProShares Ultra Nasdaq Biotechnology is 67.24%, recorded on Jun 27, 2016. It took 1152 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-67.24%Jul 21, 2015237Jun 27, 20161152Jan 25, 20211389
-41.44%May 13, 201160Aug 8, 2011112Jan 18, 2012172
-39.01%Feb 26, 201433Apr 11, 2014114Sep 24, 2014147
-36.3%Apr 16, 201054Jul 1, 2010118Dec 17, 2010172
-29.33%Feb 9, 202166May 13, 2021
-24.73%Oct 8, 201227Nov 15, 201271Mar 1, 201398
-20.33%May 15, 201326Jun 20, 201314Jul 11, 201340
-17.74%Mar 23, 201528Apr 30, 201534Jun 18, 201562
-17.57%Oct 2, 20136Oct 9, 201332Nov 22, 201338
-16.83%Sep 25, 201414Oct 14, 20147Oct 23, 201421

BIBVolatility Chart

Current ProShares Ultra Nasdaq Biotechnology volatility is 22.82%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (S&P 500)

Portfolios with ProShares Ultra Nasdaq Biotechnology


Loading data...

More Tools for ProShares Ultra Nasdaq Biotechnology